Health Events Local 2026-03-27T06:48:50+00:00

Mexican Hospital Strengthens Kidney Transplant Program with Advanced Technology

The Hospital Juárez de México (HJM) has consolidated its renal transplant program by incorporating cutting-edge technology and specialized care, optimizing clinical outcomes for patients with advanced kidney disease. The institution utilized specialized tools such as histocompatibility testing, flow cytometry, and detection of cell-free DNA in peripheral blood. These technologies enabled the evaluation of donor-recipient compatibility and early detection of potential organ rejection.


The Hospital Juárez de México (HJM) has consolidated its renal transplant program by incorporating cutting-edge technology and specialized care, optimizing clinical outcomes for patients with advanced kidney disease. Diagnostic technology: key to compatibility and monitoring. The institution utilized specialized tools such as histocompatibility testing, flow cytometry, and detection of cell-free DNA in peripheral blood. These technologies enabled the evaluation of donor-recipient compatibility and early detection of potential organ rejection. Paulina Carpinteyro Espín, head of the Transplant Division, explained that these studies were complemented by kidney biopsies to identify disease reactivation in the graft. Innovative strategies to expand transplant access. HJM implemented a cross-transplant scheme, allowing patients with incompatible donors to undergo the procedure through organ exchange; to date, eight interventions have been performed under this model. Additionally, transplants were carried out on highly sensitized patients using immunosuppressive therapies that increased the chances of clinical success. The hospital provided continuous care, including free immunosuppressive medications and treatments for complications, ensuring therapeutic follow-up and improved health outcomes. Clinical outcomes aligned with international standards. In terms of clinical performance, HJM reported a three-year survival rate of nearly 98% for transplants from living donors and 96% from deceased donors, figures consistent with international standards. Since the program's inception in 1991, the institution has accumulated 528 kidney transplants, 307 from living donors and 221 from deceased donors. As of March 2026, over 15,500 people were on the waiting list for a kidney transplant in Mexico, highlighting the magnitude of the public health challenge. In this context, Paulina Carpinteyro emphasized that transplantation is the only potentially curative treatment for many people, urging the public to promote a culture of donation and communicate this decision to their families. Specialized support in the donation process. The specialist also highlighted the role of the hospital donation coordinator, who has specialized training to provide support to families during the process, facilitating decision-making with sensitivity and professionalism.